ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1574

The Role of Shelterin Deficiency in the Senescence in T Cells of Rheumatoid Arthritis

Wenjie Zheng1, Lili Zhang2, Hua Chen3 and Yan Zhao1, 1Rheumatology, Peking Union Medical College Hospital, Beijing, China, 2Infection and Immunity, Tianjin people's hospital, Tianjing, China, 3Peking Union Medical College Hospital, Beijing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: T cells, Telomeres and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: T cells abnormality is an essential part in the pathogenesis of rheumatoid arthritis (RA), which includes a signature of premature immune aging, and restricted proliferative potential of naïve T cells. Shelterin complex is critical for maintaining Telomeres, which are important regulators of aging. We hypothesized that shelterin deficiency may play a key role in the senescence of RA T cells.

Methods: Naïve CD4 T cells were isolated from 29 Newly-onset treatment-naive RA patients and 38 gender-and age- matched healthy controls (HC) . The expression of six shelterin subunits was assessed in naïve and activated CD4 T cells. Critical DNA damage responses and the role of TRF2 in cell apoptosis were tested as well.

Results: The mRNA levels of subunits TRF1, TRF2, Rap1 and TPP1, except POT1 and TIN2, were significantly lower in RA naïve CD4 T cells compare with those from HC. TCR stimulation significantly up-regulated all subunit expression in both group in a time-dependent manner, but the level of healthy controls remained higher than RA patients. Additionally, the deficiency of shelterin subunits were independent of disease activity (measured by DAS28), disease duration or treatment. Consistently, DNA lesions related to apoptosis triggers, including ATM, CHK2, H2AX histone, p53, p21 and GADD45, were up-regulated in RA naïve CD4 T cells compared with HC. Finally, by TRF2-silencing, we showed loss of telomere protection by shelterin ultimately resulted in ATM-p53-dependent DNA damage response in naïve CD4 T cells, which was correlated with caspase-3 activation.

Conclusion: Shelterin deficiency of naïve CD4 T cells in RA patient may be involed in the perturbed T cell homeostasis, and restore T cell competence may be a potential therapeutic target.


Disclosure: W. Zheng, None; L. Zhang, None; H. Chen, None; Y. Zhao, None.

To cite this abstract in AMA style:

Zheng W, Zhang L, Chen H, Zhao Y. The Role of Shelterin Deficiency in the Senescence in T Cells of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-role-of-shelterin-deficiency-in-the-senescence-in-t-cells-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-shelterin-deficiency-in-the-senescence-in-t-cells-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology